Organisation paid for research Program year 2025 Source: CMS Open Payments

Aesthetic Solutions PA

Neither a doctor nor a teaching hospital

Research payments

$1,475,775

135 payments

Through program year 2025, Aesthetic Solutions PA is reported as receiving $1,475,775 in research payments, across 135 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$4,781	1
2024	Research	$48,674	9
2023	Research	$208,688	28
2022	Research	$1,026,830	61
2021	Research	$67,052	13
2020	Research	$86,759	14
2019	Research	$32,992	9

Breakdown

Who paid Research payments · program years 2019–2025

AbbVie, Inc. $1,265,279 95 payments
Allergan Inc. $210,496 40 payments

Studies the money was for Research payments · program years 2019–2025

A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines $493,843 12 payments
A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines $254,338 12 payments
A Study to Assess Adverse Events and Change in Disease Activity of JUVEDERM VOLITE XC Injectable Gel for Change in Neck Appearance in Adult Participants $146,064 16 payments
A Study To Assess the Safety of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence $121,300 21 payments
A Study to Assess Adverse Events and Change in Disease Activity of JUV?DERM? VOLITE? XC Injectable Gel for Change in Neck Appearance in Adult Participants $106,565 7 payments
A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence $94,456 15 payments
Voluma Temple US $77,399 13 payments
Voluma Temple US $68,623 9 payments
A multicenter, evaluator-blinded, randomized, parallel-group, controlled study of the safety and effectiveness of Juvederm VOLUMA XC injectable gel for restoring jawline definition $31,771 11 payments
A Study to Assess Adverse Events and Change in Disease Activity of JUV/DERM/ VOLITE/XC Injectable Gel for Change in Neck Appearance in Adult Participants $23,848 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.